GSK vs MERC · P/E 13, $103.31B cap vs rev $949.6M
GlaxoSmithKline PLC ADR (GSK) versus Mercer International Inc (MERC) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Mercer International Inc (MERC) is a paper & paper products company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported MERC revenue for 2026-06-30 was $949.6M. Net income was -$128.0M. Revenue was up 94.1% from 2026-03-31 to 2026-06-30. MERC currently screens at market cap $59.2M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. MERC currently screens at market cap $59.2M.
Not investment advice. Open the GSK and MERC stock pages for the full models.
Not investment advice.